Oura announced a $625 million cash agreement to acquire Counsel Health and expand physician-supported care inside its app.

Oura agrees to buy Counsel Health for $625M

Oura agrees to buy Counsel Health for $625M

Image: AI-generated editorial illustration

Oura said on November 10, 2026, that it has agreed to acquire Counsel Health in a $625 million cash deal, extending its push from health tracking into physician-supported care. The transaction is not yet closed and is expected to finish near the end of 2026, subject to customary conditions.

What did Oura agree to buy?

Oura said it has agreed to acquire Counsel Health, an AI-native, physician-supervised primary-care platform, in a cash deal valued at $625 million. The companies announced the agreement on November 10, 2026, and described it as a definitive agreement rather than a completed acquisition.

The deal is intended to deepen Oura’s healthcare offering beyond health tracking and into physician-supported care inside the Oura ecosystem. Oura said it had partnered with Counsel Health since May 2026 before signing the acquisition agreement.

How does Counsel Health fit into Oura’s product?

Counsel Health provides a chat-based medical experience with access to licensed physicians, and Oura said the service is designed to work with biometric data from its smart rings. Oura said Counsel physicians can access user data only with permission, and more than half of Counsel users in Oura Labs had already shared their Oura data with physicians since the partnership began.

Oura also said Counsel physicians can diagnose, treat, order labs, and prescribe when appropriate. The company said the app experience includes Health Radar, Health Panels, and Symptom Radar, which are the features involved in connecting ring data to care.

MedTech Dive reported that the combined model is meant to bridge consumer wearable data and physician oversight, while Oura said Counsel’s platform would help move the company toward physician-supported care rather than only health tracking.

Why is this acquisition important for Oura’s strategy?

The companies said they plan to expand the combined offering across preventive, acute, specialty, and chronic care. TechCrunch quoted Oura CEO Tom Hale as saying the goal is to cover needs ranging from quick questions and prescriptions to lab results, chronic care, and referrals.

Business Wire said Counsel will continue serving existing and new enterprise partners after the acquisition and is expected to expand its AI-native care model beyond Oura’s member base. That suggests the company is not being folded solely into Oura’s consumer app, but is expected to keep operating in enterprise settings as well.

TechCrunch also reported the acquisition follows Oura postponing its planned IPO indefinitely a few weeks earlier, while Counsel’s service had already been integrated into the Oura app in June 2026.

What do the companies say about scale and what happens next?

Oura said it has more than six million members and reported 153% year-over-year revenue growth to $533 million for the quarter ended September 30, 2026, though those are company-reported figures. TechCrunch separately reported Oura said fiscal 2026 revenue was about $1.75 billion, up 92% year over year, and that the company reached an $11 billion valuation after a $900 million late-stage round in October 2025.

On Counsel’s side, TechCrunch reported the startup raised a $25 million Series A led by Andreessen Horowitz and GV about a year earlier, and cited PitchBook’s estimate that Counsel had raised $36 million in total. TechCrunch also reported Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, and Bloomberg reported the startup had 70 employees.

The transaction had not closed at announcement. Oura said it expects the acquisition to close near the end of 2026, subject to customary closing conditions. Startups Acquired said the deal was the largest disclosed startup acquisition in the week of November 9, 15, 2026, and listed it as a cash deal for an AI primary care startup.

Sources